Transaction in Own Shares

Summary by AI BETAClose X

On September 17, 2025, GSK plc announced the purchase of 210,377 of its ordinary shares, with a nominal value of 31¼ pence each, on September 16, 2025. The shares were bought at prices ranging from 1,462.00p to 1,478.00p per share, with a volume-weighted average price of 1,468.98p. These shares will be held as treasury shares as part of an existing buyback program, bringing the total purchased since June 4, 2025, to 29,104,717 ordinary shares. Following this transaction, GSK will hold 247,239,100 ordinary shares in treasury, with 4,068,163,868 ordinary shares in issue, excluding treasury shares; the percentage of voting rights attributable to ordinary shares held in treasury is 6.08 per cent.

Disclaimer*

Companies

GSK (GSK)
UK 100

Latest directors dealings